The assessment of vascular function during dietary intervention trials in human subjects

British Journal of Nutrition

Volumn 106, Issue 7, 2011, Pages 981-994

  McCall, Damian O ^a   McKinley, Michelle C ^a   Noad, Rebecca ^a   McKeown, Pascal P ^a   McCance, David R ^b   Young, Ian S ^a   Woodside, Jayne V ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Dietary intervention; Endothelium; Pulse wave analysis; Pulse wave velocity

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; VASODILATOR AGENT;

ABDOMINAL OBESITY; ARTERY PUNCTURE; BRACHIAL ARTERY; CACAO; CARDIOVASCULAR FUNCTION; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; FOOD INTAKE; HUMAN; LOW FAT DIET; MEDITERRANEAN DIET; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREHYPERTENSION; PROVOCATION TEST; PULSE WAVE; REVIEW; VASODILATATION; ARTERY; CARDIOVASCULAR DISEASE; ELASTICITY; METHODOLOGY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PULSE RATE; RESEARCH; VASCULAR ENDOTHELIUM;

ARTERIES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ELASTICITY; ENDOTHELIUM, VASCULAR; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PULSE; RESEARCH; VASODILATION;

EID: 84856087866     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002996     Document Type: Review

References (175)

1. He FJ, Nowson CA & MacGregor GA (2006) Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 367, 320-326. (Pubitemid 43151465)
2. Trichopoulou A, Costacou T, Bamia C, et al. (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 2599-2608. (Pubitemid 36741587)
3. Appel LJ, Moore TJ, Obarzanek E, et al. (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336, 1117-1124.
4. Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid- rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 38-50. (Pubitemid 351988681)
5. Félétou M & Vanhoutte PM (2006) Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291, H985-H1002. (Pubitemid 44343640)
6. Davignon J & Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109, Suppl. 1, 27-32.
7. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352, 1685-1695.
8. Tousoulis D, Antoniades C & Stefanadis C (2005) Evaluating endothelial function in humans: A guide to invasive and non-invasive techniques. Heart 91, 553-558. (Pubitemid 40432802)
9. Celermajer DS, Sorensen KE, Gooch VM, et al. (1992) Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111-1115.
10. Corretti MC, Anderson TJ, Benjamin EJ, et al. (2002) Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39, 257-265. (Pubitemid 34084631)
11. Deanfield J, Donald A, Ferri C, et al. (2005) Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23, 7-17. (Pubitemid 40128972)
12. Lekakis J, Papamichael C, Vemmos C, et al. (1997) Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 79, 529-531. (Pubitemid 127440432)
13. Schnell GB, Robertson A, Houston D, et al. (1999) Impaired brachial artery endothelial function is not predicted by elevated triglycerides. J Am Coll Cardiol 33, 2038-2043.
14. Evans M, Anderson RA, Graham J, et al. (2000) Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 101, 1773-1779. (Pubitemid 30213097)
15. Brevetti G, Silvestro A, Schiano V, et al. (2003) Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108, 2093-2098. (Pubitemid 37337585)
16. Gokce N, Keaney JF Jr, Hunter LM, et al. (2002) Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 105, 1567-1572. (Pubitemid 34297634)
17. Patti G, Pasceri V, Melfi R, et al. (2005) Impaired flowmediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 111, 70-75. (Pubitemid 40070846)
18. Yeboah J, Crouse JR, Hsu FC, et al. (2007) Brachial flowmediated dilation predicts incident cardiovascular events in older adults: The Cardiovascular Health Study. Circulation 115, 2390-2397. (Pubitemid 46717961)
19. Egert S & Stehle P (2011) Impact of n-3 fatty acids on endothelial function: Results from human intervention studies. Curr Opin Nutr Metab Care 14, 121-131.
20. Chong MF, Macdonald R & Lovegrove JA (2010) Fruit polyphenols and CVD risk: A review of human intervention studies. Br J Nutr 104, S28-S39.
21. Basu A, Rhone M & Lyons TJ (2010) Berries: Emerging impact on cardiovascular health. Nutr Rev 68, 168-177.
22. Moore RJ, Jackson KG & Minihane AM (2009) Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 102, 1790-1802.
23. Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S-388S. (Pubitemid 47579907)
24. Balzer J, Rassaf T, Heiss C, et al. (2008) Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients. J Am Coll Cardiol 51, 2141-2149. (Pubitemid 351713684)
25. Berry NM, Davison K, Coates AM, et al. (2010) Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br J Nutr 103, 1480-1484.
26. Davison K, Coates AM, Buckley JD, et al. (2008) Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes 32, 1289-1296.
27. Engler MB, Engler MM, Chen YV, et al. (2004) Flavonoidrich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197-204. (Pubitemid 38746107)
28. Faridi Z, Njike VY, Dutta S, et al. (2008) Acute dark chocolate and cocoa ingestion and endothelial function: A randomised controlled crossover trial. Am J Clin Nutr 88, 58-63. (Pubitemid 351988683)
29. Farouque HMO, Leung M, Hope SA, et al. (2006) Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: A randomised double-blind placebo-controlled study. Clin Sci 111, 71-80. (Pubitemid 44023413)
30. Grassi D, Necozione S, Lippi C, et al. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398-405. (Pubitemid 41099176)
31. Heiss C, Dejam A, Kleinbongard P, et al. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030-1031. (Pubitemid 37430442)
32. Heiss C, Finis D, Kleinbongard P, et al. (2007) Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 49, 74-80.
33. Heiss C, Jahn S, Taylor M, et al. (2010) Improvement of endothelial function with dietary flavanols is associated with mobilisation of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol 56, 218-224.
34. Hermann F, Spieker LE, Ruschitzka F, et al. (2006) Dark chocolate improves endothelial and platelet function. Heart 92, 119-120. (Pubitemid 43021877)
35. Sanderson P, Sattar N, Olthof M, et al. (2004) Dietary lipids and vascular function: UK Food Standards Agency workshop report. Br J Nutr 91, 491-500. (Pubitemid 38386914)
36. De Roos NM, Bots ML, Schouten EG, et al. (2003) Withinsubject variability of flow-mediated vasodilation of the brachial artery in healthy men and women: Implications for experimental studies. Ultrasound Med Biol 29, 401-406. (Pubitemid 36434328)
37. Donald AE, Charakida M, Cole TJ, et al. (2006) Non-invasive assessment of endothelial function: Which technique? J Am Coll Cardiol 48, 1846-1850. (Pubitemid 44648611)
38. Donald AE, Halcox JP, Charakida M, et al. (2008) Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 51, 1959-1964. (Pubitemid 351636449)
39. Tschakovsky ME & Pyke KE (2005) Counterpoint: Flowmediated dilation does not reflect nitric oxide-mediated endothelial function. J Appl Physiol 99, 1235-1237.
40. Mullen MJ, Kharbanda RK, Cross J, et al. (2001) Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: Relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 88, 145-151. (Pubitemid 32147301)
41. Fathi R, Haluska B, Isbel N, et al. (2004) The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 43, 616-623. (Pubitemid 38229534)
42. Frick M, Suessenbacher A, Alber HF, et al. (2005) Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 46, 1006-1010. (Pubitemid 41316507)
43. Deanfield JE, Halcox JP & Rabelink TJ (2007) Endothelial function and dysfunction: Testing and clinical relevance. Circulation 115, 1285-1295. (Pubitemid 46594773)
44. Widlansky ME (2009) Shear stress and flow-mediated dilation: All shear responses are not created equally. Am J Physiol Heart Circ Physiol 296, H31-H32.
45. Mitchell GF, Parise H, Vita JA, et al. (2004) Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension 44, 134-139. (Pubitemid 39014228)
46. Huang AL, Silver AE, Shvenke E, et al. (2007) Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27, 2113-2119. (Pubitemid 350287238)
47. Philpott A & Anderson TJ (2007) Reactive hyperemia and cardiovascular risk. Arterioscler Thromb Vasc Biol 27, 2065-2067. (Pubitemid 350287232)
48. Furchgott RF & Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376. (Pubitemid 11169009)
49. Ludmer PL, Selwyn AP, Shook TL, et al. (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315, 1046-1051. (Pubitemid 17170620)
50. Al Suwaidi J, Higano ST, Holmes DR Jr, et al. (2001) Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37, 1523-1528.
51. Schachinger V, Britten MB & Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899-1906. (Pubitemid 30225269)
52. Halcox JP, Schenke WH, Zalos G, et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658. (Pubitemid 34851922)
53. Targonski PV, Bonetti PO, Pumper GM, et al. (2003) Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 107, 2805-2809. (Pubitemid 36705990)
54. Hirooka Y, Imaizumi T, Tagawa T, et al. (1994) Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 90, 658-668. (Pubitemid 24242730)
55. Tagawa T, Mohri M, Tagawa H, et al. (1997) Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. J Cardiovasc Pharmacol 29, 546-553. (Pubitemid 27212760)
56. Perticone F, Ceravolo R, Pujia A, et al. (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104, 191-196. (Pubitemid 32655837)
57. Heitzer T, Schlinzig T, Krohn K, et al. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678. (Pubitemid 33108132)
58. Fichtlscherer S, Breuer S & Zeiher AM (2004) Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: Further evidence for the existence of the "vulnerable" patient. Circulation 110, 1926-1932. (Pubitemid 39331903)
59. Wilkinson IB & Webb DJ (2001) Venous occlusion plethysmography in cardiovascular research: Methodology and clinical applications. Br J Clin Pharmacol 52, 631-646. (Pubitemid 34015621)
60. Singh N, Graves J, Taylor PD, et al. (2002) Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 56, 118-125. (Pubitemid 35247808)
61. Ambring A, Friberg P, Axelsen M, et al. (2004) Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci 106, 519-525. (Pubitemid 38639556)
62. Tzemos N, Lim PO, Wong S, et al. (2008) Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 51, 1525-1530.
63. McCall DO, McGartland CP, McKinley MC, et al. (2009) Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 119, 2153-2160.
64. Benjamin N, Calver A, Collier J, et al. (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25, 918-923.
65. Kennedy AM, Grocott M, Schwartz MS, et al. (1997) Median nerve injury: An underrecognised complication of brachial artery cardiac catheterisation? J Neurol Neurosurg Psychiatry 63, 542-546. (Pubitemid 27423571)
66. Morris SJ & Shore AC (1996) Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: Possible mechanisms. J Physiol (Lond) 496, 531-542. (Pubitemid 26370923)
67. Kvandal P, Stefanovska A, Veber M, et al. (2003) Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: Importance of nitric oxide and prostaglandines. Microvasc Res 65, 160-171. (Pubitemid 36438682)
68. Debbabi H, Bonnin P, Ducluzeau PH, et al. (2010) Noninvasive assessment of endothelial function in the skin microcirculation. Am J Hypertens 23, 541-546.
69. George TW, Niwat C, Waroonphan S, et al. (2009) Effects of chronic and acute consumption of fruit- and vegetablepuree- based drinks on vasodilation, risk factors for CVD and the response as a result of the eNOS G298T polymorphism. Proc Nutr Soc 68, 148-161.
70. Frank J, George TW, Lodge JK, et al. (2009) Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 139, 58-62.
71. Armah CK, Jackson KG, Doman I, et al. (2008) Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clin Sci 114, 679-686. (Pubitemid 351799327)
72. Hamdy O, Ledbury S, Mullooly C, et al. (2003) Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26, 2119-2125. (Pubitemid 41184262)
73. Morand C, Dubray C, Milenkovic D, et al. (2011) Hesperidin contributes to the vascular protective effects of orange juice: A randomised crossover study in healthy volunteers. Am J Clin Nutr 93, 73-80.
74. Hamilton PK, Lockhart CJ, Quinn CE, et al. (2007) Arterial stiffness: Clinical relevance, measurement and treatment. Clin Sci 113, 157-170. (Pubitemid 47237913)
75. Pase MP, Grima NA & Sarris J (2011) The effects of dietary and nutrient interventions on arterial stiffness: A systematic review. Am J Clin Nutr 93, 446-454.
76. Oliver JJ & Webb DJ (2003) Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23, 554-566. (Pubitemid 36438066)
77. Hughes SM, Dixon LJ & McVeigh GE (2004) Arterial stiffness and pulse wave velocity: Problems with terminology. Circulation 109, e3.
78. Schillaci G, Pirro M, Vaudo G, et al. (2005) Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45, 1078-1082. (Pubitemid 40770308)
79. Laurent S, Katsahian S, Fassot C, et al. (2003) Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34, 1203-1206. (Pubitemid 36547514)
80. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. (2006) Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation 113, 657-663.
81. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113, 664-670.
82. Pannier B, Guerin AP, Marchais SJ, et al. (2005) Stiffness of capacitive and conduit arteries: Prognostic significance for end-stage renal disease patients. Hypertension 45, 592-596. (Pubitemid 40411265)
83. Safar ME & Laurent P (2003) Pulse pressure and arterial stiffness in rats: Comparison with humans. Am J Physiol Heart Circ Physiol 285, H1363-H1369. (Pubitemid 37169487)
84. Payne RA & Webb DJ (2006) Arterial blood pressure and stiffness in hypertension: Is arterial structure important? Hypertension 48, 366-367. (Pubitemid 44253725)
85. O'Rourke MF & Nichols WW (2005) Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 45, 652-658. (Pubitemid 40418361)
86. Dengo AL, Dennis EA, Orr JS, et al. (2010) Arterial destiffening with weight loss in overweight and obese middle-aged and older adults. Hypertension 55, 855-861.
87. Blumenthal JA, Babyak MA, Hinderliter A, et al. (2010) Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study. Arch Intern Med 170, 126-135.
88. Keogh JB, Brinkworth GD, Noakes M, et al. (2008) Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 87, 567-576. (Pubitemid 351364536)
89. Philippou E, Bovill-Taylor C, Rajkumar C, et al. (2009) Preliminary report: The effect of a 6-month dietary glycemic index manipulation in addition to healthy eating advice and weight loss on arterial compliance and 24-hour ambulatory blood pressure in men: A pilot study. Metabolism 58, 1703-1708.
90. Todd AS, Macginley RJ, Schollum JB, et al. (2010) Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr 91, 557-564.
91. Sluijs I, Plantinga Y, de Roos B, et al. (2010) Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 91, 175-183.
92. Dickinson KM, Keogh JB & Clifton PM (2009) Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 89, 485-490.
93. Teede HJ, McGrath BP, DeSilva L, et al. (2003) Isoflavones reduce arterial stiffness: A placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 23, 1066-1071. (Pubitemid 36713562)
94. Wilkinson IB, MacCallum H, Cockcroft JR, et al. (2002) Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53, 189-192. (Pubitemid 34264274)
95. Schmitt M, Avolio A, Qasem A, et al. (2005) Basal NO locally modulates human iliac artery function in vivo. Hypertension 46, 227-231. (Pubitemid 40946519)
96. McEniery CM, Wallace S, Mackenzie IS, et al. (2006) Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 48, 602-608. (Pubitemid 44843862)
97. Wallace SM, Yasmin, McEniery CM, et al. (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50, 228-233. (Pubitemid 46986045)
98. McCall DO, McGartland CP, Woodside JV, et al. (2010) The relationship between microvascular endothelial function and carotid-radial pulse wave velocity in patients with mild hypertension. Clin Exp Hypertens 32, 474-479.
99. Oparil S & Izzo JL Jr (2006) Pulsology rediscovered: Commentary on the Conduit Artery Function Evaluation (CAFE) study. Circulation 113, 1162-1163.
100. Karamanoglu M, O'Rourke MF, Avolio AP, et al. (1993) An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14, 160-167. (Pubitemid 23089501)
101. Chen CH, Nevo E, Fetics B, et al. (1997) Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 95, 1827-1836. (Pubitemid 27164400)
102. Weber T, Auer J, O'Rourke MF, et al. (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109, 184-189. (Pubitemid 38114137)
103. London GM, Blacher J, Pannier B, et al. (2001) Arterial wave reflections and survival in end-stage renal failure. Hypertension 38, 434-438. (Pubitemid 34225679)
104. Mitchell GF, Hwang S-J, Ramachandran RS, et al. (2010) Arterial stiffness and cardiovascular events - The Framingham Heart Study. Circulation 121, 505-511.
105. Booth AD, Wallace S, McEniery CM, et al. (2004) Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation. Arthritis Rheum 50, 581-588. (Pubitemid 38198843)
106. Dart AM, Gatzka CD, Cameron JD, et al. (2004) Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol 24, 962-968. (Pubitemid 38620879)
107. Yasmin & Brown MJ (1999) Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM 92, 595-600. (Pubitemid 29501966)
108. Wilkinson IB, MacCallum H, Flint L, et al. (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol (Lond) 525, 263-270. (Pubitemid 30311951)
109. Ahuja KD, Robertson IK & Ball MJ (2009) Acute effects of food on postprandial blood pressure and measures of arterial stiffness in healthy humans. Am J Clin Nutr 90, 298-303.
110. Bradley U, Spence M, Courtney CH, et al. (2009) Low-fat versus low-carbohydrate weight reduction diets: Effects on weight loss, insulin resistance, and cardiovascular risk: A randomized control trial. Diabetes 58, 2741-2748.
111. Albert MA & Ridker PM (2006) C-reactive protein as a risk predictor: Do race/ethnicity and gender make a difference? Circulation 114, e67-e74. (Pubitemid 44264805)
112. Ridker PM, Danielson E, Fonseca FA, et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359, 2195-2207.
113. Berry SE, Mulla UZ, Chowienczyk PJ, et al. (2010) Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: A randomised controlled trial. Br J Nutr 104, 1839-1847.
114. Blum A, Monir M, Khazim K, et al. (2007) Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med 30, E70-E74. (Pubitemid 47535695)
115. Dalgard C, Nielsen F, Morrow JD, et al. (2009) Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br J Nutr 101, 263-269.
116. Erlinger TP, Miller ER, Charleston J, et al. (2003) Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids. Results from the DASH-sodium trial. Circulation 108, 150-154. (Pubitemid 36871295)
117. Esposito K, Marfella R, Ciotola M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 292, 1440-1446. (Pubitemid 39258336)
118. Freese R, Vaarala O, Turpeinen AM, et al. (2004) No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apples in healthy subjects. Eur J Nutr 43, 175-182. (Pubitemid 38828666)
119. Jin Y, Cui X, Singh UP, et al. (2010) Systemic inflammatory load in humans is suppressed by consumption of two formulations of dried, encapsulated juice concentrate. Mol Nutr Food Res 54, 1506-1514.
120. Karlsen A, Paur I, Bohn SK, et al. (2010) Bilberry juice modulates plasma concentration of NF-kB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 49, 345-355.
121. Lehtonen H-M, Suomela J-P, Tahvonen R, et al. (2010) Berry meals and risk factors associated with metabolic syndrome. Eur J Clin Nutr 64, 614-621.
122. McCall DO, McGartland CP, McKinley MC, et al. (2010) The effect of increased dietary fruit and vegetable consumption on endothelial activation, inflammation and oxidative stress in hypertensive volunteers. Nutr Metab Cardiovasc Dis (Epublication ahead of print version 12 April 2010).
123. Mena M-P, Sacanella E, Vazquez-Agell M, et al. (2009) Inhibition of circulating immune cell activation: A molecular anti-inflammatory effect of the Mediterranean diet. Am J Clin Nutr 89, 248-256.
124. Michalsen A, Lehmann N, Pithan C, et al. (2006) Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur J Clin Nutr 60, 478-485.
125. Paterson E, Gordon MH, Niwat C, et al. (2006) Supplementation with fruit and vegetable soups and beverages increases plasma concentrations but does not alter markers of oxidative stress or cardiovascular risk factors. J Nutr 136, 2849-2855. (Pubitemid 44771785)
126. Rallidis LS, Lekakis J, Kolomvotsou A, et al. (2009) Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity. Am J Clin Nutr 90, 263-268.
127. Stull AJ, Cash KC, Johnson WD, et al. (2010) Bioactives in blueberries improve insulin sensitivity in obese, insulinresistant men and women. J Nutr 140, 1764-1768.
128. Watzl B, Kulling SE, Moseneder J, et al. (2005) A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 82, 1052-1058. (Pubitemid 43779764)
129. Giugliano D, Ceriello A & Esposito K. (2006) The effect of diet on inflammation: Emphasis on the metabolic syndrome. J Am Coll Cardiol 48, 677-685. (Pubitemid 44175717)
130. Ferrario CM & Strawn WB (2006) Role of the renin-angiotensin- aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98, 121-128. (Pubitemid 43902687)
131. Hwang SJ, Ballantyne CM, Sharrett AR, et al. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study. Circulation 96, 4219-4225. (Pubitemid 28007447)
132. Brake DK, O'Brian Smith E, Mersmann H, et al. (2006) ICAM-1 expression in adipose tissue: Effects of diet-induced obesity in mice. Am J Physiol 291, C1232-C1239. (Pubitemid 44878594)
133. Rallidis LS, Paschos G, Papaioannou ML, et al. (2004) The effect of diet enriched with a-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 174, 127-132. (Pubitemid 38595450)
134. Atteritano M, Marini H, Minutoli L, et al. (2007) Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 92, 3068-3075. (Pubitemid 47236372)
135. Kelley DS, Rasooly R, Jacob RA, et al. (2006) Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 136, 981-986.
136. Chisolm GM & Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: An overview. Free Radic Biol Med 28, 1815-1826. (Pubitemid 30628668)
137. Roberts LJ & Morrow JD (2000) Measurement of F-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28, 505-513. (Pubitemid 30136031)
138. Thompson HJ, Heimendinger J, Sedlacek S, et al. (2005) 8-Isoprostane F2a excretion is reduced in women by increased vegetable and fruit intake. Am J Clin Nutr 82, 768-776. (Pubitemid 43779689)
139. O'Reilly JD, Mallet AI, McAnlis GT, et al. (2001) Consumption of flavonoids in onions and black tea: Lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73, 1040-1044. (Pubitemid 32496942)
140. Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018-1025.
141. Zalewski A & Macphee C (2005) Role of lipoproteinassociated phospholipase A2 in atherosclerosis: Biology, epidemiology and possible therapeutic target. Arterioscler Thromb Vasc Biol 25, 923-931. (Pubitemid 40627835)
142. Packard CJ, O'Reilly DSJ, Caslake MJ, et al. (2000) Lipoprotein- associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med 343, 1148-1155.
143. Thogerson AM, Jansson J, Boman K, et al. (1998) High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98, 2241-2247. (Pubitemid 28533841)
144. Thompson SG, Kienast J, Pyke SD, et al. (1995) Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332, 635-641.
145. Hamsten A, de Faire U, Walldius G, et al. (1987) Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet ii, 3-9. (Pubitemid 17083665)
146. Bakker GC, van Erk MJ, Pellis L, et al. (2010) An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: A nutrigenomics approach. Am J Clin Nutr 91, 1044-1059.
147. Shantsila E (2009) Endothelial microparticles: A universal marker of vascular health? J Hum Hypertens 23, 359-361.
148. Amabile N, Guerin AP, Leroyer A, et al. (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16, 3381-3388. (Pubitemid 46179341)
149. Boulanger CM, Scoazec A, Ebrahimian T, et al. (2001) Circulating
150. Brodsky SV, Malinowski K, Golightly M, et al. (2002) Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106, 2372-2378. (Pubitemid 35244740)
151. Mallat Z, Benamer H, Hugel B, et al. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843. (Pubitemid 30117876)
152. Heloire F, Weill B, Weber S, et al. (2003) Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction. Thromb Res 110, 173-180. (Pubitemid 37338289)
153. Jimenez JJ, Jy W, Mauro LM, et al. (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109, 175-180. (Pubitemid 36712905)
154. Mallat Z, Hugel B, Ohan J, et al. (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353. (Pubitemid 29051259)
155. Bernal-Mizrachi L, Jy W, Fierro C, et al. (2004) Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 97, 439-446. (Pubitemid 39550693)
156. Koga H, Sugiyama S, Kugiyama K, et al. (2005) Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45, 1622-1630. (Pubitemid 40704497)
157. Arteaga RB, Chirinos JA, Soriano AO, et al. (2006) Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98, 70-74. (Pubitemid 43902682)
158. Garcia S, Chirinos J, Jiminez J, et al. (2005) Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: Switch from cell activation to apoptosis. J Heart Lung Transplant 24, 2184-2189. (Pubitemid 41814744)
159. Wang JM, Su C, Wang YJ, et al. (2009) Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens 23, 307-315.
160. Harrison M, Murphy RP, O'Connor PL, et al. (2009) The endothelial microparticle response to a high fat meal is not attenuated by prior exercise. Eur J Appl Physiol 106, 555-562.
161. Marin C, Ramirez R, Delgado-Lista J, et al. (2011) Mediterranean diet reduces endothelial damage and improves the regenerative capacity of the endothelium. Am J Clin Nutr 93, 267-274.
162. Asahara T, Murohara T, Sullivan A, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967. (Pubitemid 27087709)
163. Shintani S, Murohara T, Ikeda H, et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-2779. (Pubitemid 32550062)
164. Wojakowski W, Tendera M, Michalowska A, et al. (2004) Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110, 3213-3220. (Pubitemid 39525068)
165. Werner N & Nickenig G (2006) Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arterioscler Thromb Vasc Biol 26, 257-266. (Pubitemid 43732183)
166. Vasa M, Fichtlscherer S, Aicher A, et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89, 1-7.
167. Hill JM, Zalos G, Halcox JP, et al. (2003) Circulating endothelial progenitor cells, vascular function, cardiovascular risk. N Engl J Med 348, 593-600. (Pubitemid 36204953)
168. Werner N, Kosiol S, Schiegl T, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007. (Pubitemid 41262334)
169. Müller-Ehmsen J, BraunD, Schneider T, etal. (2008)Decreased number of circulating progenitor cells in obesity: Beneficial effects of weight reduction. Eur Heart J 29, 1560-1568. (Pubitemid 351881989)
170. Kim W, Jeong MH, Cho SH, et al. (2006) Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 70, 1052-1057. (Pubitemid 44161745)
171. Mano R, Ishida A, Ohya Y, et al. (2009) Dietary intervention with Okinawan vegetables increased circulating endothelial progenitor cells in healthy young women. Atherosclerosis 204, 544-548.
172. Huang PH, Chen YH, Tsai HY, et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30, 869-877.
173. Hamed S, Alshiek J, Aharon A, et al. (2010) Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals. Am J Clin Nutr 92, 161-169.
174. Boof CJ, Lip GYH & Blann AD (2006) Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 48, 1538-1547. (Pubitemid 44550075)
175. Stirban A, Nandrean S, Gotting C, et al. (2010) Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr 91, 808-813.